These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16117451)

  • 1. Can lean body mass be used to reduce the dose of heparin and protamine for obese patients undergoing cardiopulmonary bypass?
    Baker MS; Skoyles JR; Shajar FM; Skinner H; Richens D; Mitchell IM
    J Extra Corpor Technol; 2005 Jun; 37(2):153-6. PubMed ID: 16117451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusted calculation model of heparin management during cardiopulmonary bypass in obese patients: A randomised controlled trial.
    Vienne M; Haas E; Wipf T; Grunebaum L; Levy F; Sattler L; Hoang Minh T; Severac F; Tacquard C; Collange O; Mertes PM; Steib A
    Eur J Anaesthesiol; 2018 Aug; 35(8):613-620. PubMed ID: 29521662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying optimal heparin management during cardiopulmonary bypass in obese patients: A prospective observational comparative study.
    Haas E; Fischer F; Levy F; Degirmenci SE; Grunebaum L; Kindo M; Collange O; Mertes PM; Steib A
    Eur J Anaesthesiol; 2016 Jun; 33(6):408-16. PubMed ID: 26886138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery.
    Suárez Cuenca J; Gayoso Diz P; Gude Sampedro F; Gómez Zincke JM; Rey Acuña H; Fontanillo Fontanillo MM
    J Extra Corpor Technol; 2013 Dec; 45(4):235-41. PubMed ID: 24649571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study.
    Runge M; Møller CH; Steinbrüchel DA
    J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
    Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individual heparin and protamine dosage in heart surgery].
    Preiss DU; Zobeley R
    Klin Wochenschr; 1983 Nov; 61(22):1141-6. PubMed ID: 6656176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery.
    Abuelkasem E; Mazzeffi MA; Henderson RA; Wipfli C; Monroe A; Strauss ER; Chow JH; Tanaka KA
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2153-2160. PubMed ID: 30737123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.
    Jobes DR; Aitken GL; Shaffer GW
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
    El Rouby S; Rinehart K; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less is more: We are administering too much protamine in cardiac surgery.
    De Simone F; Nardelli P; Licheri M; Frau G; Redaelli MB; Monaco F; Zangrillo A; Landoni G
    Ann Card Anaesth; 2021; 24(2):178-182. PubMed ID: 33884973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.